Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chlorexolone
1. Chlorexolone
2. 2127-01-7
3. Clorexolon
4. Flonatril
5. Nefrolan
6. Klorex
7. Q2plt3fs05
8. 6-chloro-2-cyclohexyl-3-oxo-5-isoindolinesulfonamide
9. M & B 8430
10. 1h-isoindole-5-sulfonamide, 6-chloro-2-cyclohexyl-2,3-dihydro-3-oxo-
11. 5-chloro-2-cyclohexyl-1-oxo-6-sulphamoylisoindoline
12. 6-chloro-2-cyclohexyl-3-oxoisoindoline-5-sulfonamide
13. Flonatril; Klorex; Nefrolan; Rp 12833
14. 5-isoindolinesulfonamide, 6-chloro-2-cyclohexyl-3-oxo-
15. 12833 R.p.
16. 1h-isoindole-5-sulfonamide, 2,3-dihydro-6-chloro-2-cyclohexyl-3-oxo-
17. Cloresolone [dcit]
18. Clorexolonum [inn-latin]
19. Clorexolona [inn-spanish]
20. Cloresolone
21. Clorexolona
22. Clorexolonum
23. Clorexolone [usan:inn:ban]
24. Einecs 218-342-6
25. Brn 0493411
26. Clorexolone [mi]
27. Clorexolone [inn]
28. Clorexolone [jan]
29. Clorexolone [usan]
30. Unii-q2plt3fs05
31. Clorexolone [mart.]
32. Dsstox_cid_31472
33. Dsstox_rid_97357
34. Dsstox_gsid_57683
35. Clorexolone [who-dd]
36. Schembl310673
37. Clorexolone (jan/usan/inn)
38. Zinc1199
39. 6-chloro-2-cyclohexyl-3-oxo-1h-isoindole-5-sulfonamide
40. Chembl2106167
41. Dtxsid4057683
42. Chebi:31421
43. Tox21_113742
44. 6-chloro-2-cyclohexyl-2,3-dihydro-3-oxo-1h-isoindole-5-sulfonamide
45. Db13617
46. Ncgc00253608-01
47. 12833 Rp
48. Rp 12833
49. Rp-12833
50. Cas-2127-01-7
51. D01436
52. 5-22-07-00591 (beilstein Handbook Reference)
53. J-013964
54. Q5135140
55. 6-chloro-2-cyclohexyl-3-oxo-2,3-dihydro- 1h-isoindole-5-sulfonamide
| Molecular Weight | 328.8 g/mol |
|---|---|
| Molecular Formula | C14H17ClN2O3S |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 328.0648413 g/mol |
| Monoisotopic Mass | 328.0648413 g/mol |
| Topological Polar Surface Area | 88.8 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 513 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
C - Cardiovascular system
C03 - Diuretics
C03B - Low-ceiling diuretics, excl. thiazides
C03BA - Sulfonamides, plain
C03BA12 - Clorexolone
ABOUT THIS PAGE
A Clorexolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clorexolone, including repackagers and relabelers. The FDA regulates Clorexolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clorexolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clorexolone supplier is an individual or a company that provides Clorexolone active pharmaceutical ingredient (API) or Clorexolone finished formulations upon request. The Clorexolone suppliers may include Clorexolone API manufacturers, exporters, distributors and traders.
click here to find a list of Clorexolone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clorexolone DMF (Drug Master File) is a document detailing the whole manufacturing process of Clorexolone active pharmaceutical ingredient (API) in detail. Different forms of Clorexolone DMFs exist exist since differing nations have different regulations, such as Clorexolone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clorexolone DMF submitted to regulatory agencies in the US is known as a USDMF. Clorexolone USDMF includes data on Clorexolone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clorexolone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clorexolone suppliers with USDMF on PharmaCompass.
Clorexolone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clorexolone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clorexolone GMP manufacturer or Clorexolone GMP API supplier for your needs.
A Clorexolone CoA (Certificate of Analysis) is a formal document that attests to Clorexolone's compliance with Clorexolone specifications and serves as a tool for batch-level quality control.
Clorexolone CoA mostly includes findings from lab analyses of a specific batch. For each Clorexolone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clorexolone may be tested according to a variety of international standards, such as European Pharmacopoeia (Clorexolone EP), Clorexolone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clorexolone USP).
LOOKING FOR A SUPPLIER?
